Members of the Molecular and Translational Allergology group at the Luxembourg Institute of Health (LIH) have attended the EAACI annual congress in Istanbul, June 12-15, 2026. They actively contributed to the event by chairing scientific sessions, participating in EAACI task forces and presenting their current research on inhalant allergy to pet animals and the alpha-gal syndrome, a tick-borne allergic disease.
Read the original news here: https://www.lih.lu/en/article/international-recognition-for-lih-molecular-and-translational-allergology-team-at-eaaci-congress-2026/
